Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
SURGE Therapeutics
company
About
SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $26M
- Industries
- Biotechnology
- Number Of Employee
- 1 - 10
- Operating Status
- Active
SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$26M
SURGE Therapeutics has raised a total of
$26M
in funding over 2 rounds. Their latest funding was raised on
Oct 17, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 17, 2022 | Series A | $26M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
SURGE Therapeutics is funded by 1 investors.
National Cancer Research Institute
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Cancer Research Institute
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
